Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study

被引:9
|
作者
Vanleeuw, Lieve [1 ,2 ]
Atkins, Salla [2 ,3 ]
Zembe-Mkabile, Wanga [1 ]
Loveday, Marian [4 ,5 ]
机构
[1] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa
[2] Tampere Univ, Fac Social Sci, Tampere, Finland
[3] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden
[4] South African Med Res Council, Hlth Syst Res Unit, Durban, South Africa
[5] Univ KwaZulu, Natal Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa, Durban, South Africa
来源
BMJ OPEN | 2020年 / 10卷 / 02期
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
COMMUNITY-BASED TREATMENT; HEALTH SYSTEMS; MDR-TB; HIV; INTEGRATION; PROGRAMS; OUTCOMES; NURSES;
D O I
10.1136/bmjopen-2019-032591
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Drug-resistant tuberculosis (DR-TB) is a growing concern in many low-income and middle-income countries. Facing rising numbers of DR-TB patients, South Africa (SA) introduced a decentralised model of care for DR-TB in 2011. We aimed to document the introduction and implementation of the new models of care for patients with DR-TB in four provinces (Northern Cape, KwaZulu-Natal, Eastern Cape and Gauteng) in 2015 using mixed methods, including interviews, register reviews and clinical audits. This paper reports on the qualitative component of the study. Design This is a qualitative interview study. Setting Data were collected in 22 decentralised DR-TB sites, primary healthcare facilities and district hospitals and one provincial central DR-TB hospital. Participants 58 healthcare workers (HCWs), facility staff and provincial and district TB coordinators were included in qualitative interviews. Results HCWs felt that the introduction of DR-TB care in their facility came with little warning or engagement, creating fear and anxiety. They expressed a need for support from the district and province to guide them through the changes but this support was often lacking. In addition, many respondents expressed feeling isolated and not supported by other healthcare providers which they feel impacts on the quality of the care they provide. Conclusion Introduction of a new service such as DR-TB care can be difficult and does not always result in the intended outcomes. Improved engagement with front-line providers and addressing the fear and anxiety that may be raised by changes in daily practices should be addressed to ensure successful implementation and prevent negative consequences that can hamper quality of care for patients. Attention should be paid to how the decentralised DR-TB unit can be supported by district management and other healthcare providers.
引用
收藏
页数:8
相关论文
共 29 条
  • [1] Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study
    Daftary, A.
    Padayatchi, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (11) : 1483 - 1488
  • [2] Lived experiences of patients and families with decentralised drug-resistant tuberculosis care in the Eastern Cape, South Africa
    Iruedo, Joshua O.
    Pather, Michael K.
    AFRICAN JOURNAL OF PRIMARY HEALTH CARE & FAMILY MEDICINE, 2023, 15 (01)
  • [3] Actor sensemaking and its role in implementation of the decentralized drug-resistant tuberculosis policy in South Africa
    Jassat, Waasila
    Moshabela, Mosa
    Schneider, Helen
    HEALTH POLICY AND PLANNING, 2024, 40 (02) : 183 - 193
  • [4] Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data
    Hill, J.
    Dickson-Hall, L.
    Grant, A. D.
    Grundy, C.
    Black, J.
    Kielmann, K.
    Mlisana, K.
    Mitrani, L.
    Loveday, M.
    Moshabela, M.
    Le Roux, S.
    Jassat, W.
    Nicol, M.
    Cox, H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (01) : 83 - +
  • [5] Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study
    Daftary, Amrita
    Mondal, Shinjini
    Zelnick, Jennifer
    Friedland, Gerald
    Seepamore, Boitumelo
    Boodhram, Resha
    Amico, K. Rivet
    Padayatchi, Nesri
    O'Donnell, Max R.
    LANCET GLOBAL HEALTH, 2021, 9 (04): : E479 - E488
  • [6] Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study
    Dickson, Lindy
    Le Roux, Sacha Roxanne
    Mitrani, Leila
    Hill, Jeremy
    Jassat, Waasila
    Cox, Helen
    Mlisana, Koleka
    Black, John
    Loveday, Marian
    Grant, Alison
    Kielmann, Karina
    Ndjeka, Norbert
    Moshabela, Mosa
    Nicol, Mark
    BMJ OPEN, 2023, 13 (11):
  • [7] Preferential adherence to antiretroviral therapy over tuberculosis treatment: A qualitative study of drug-resistant TB/HIV co-infected patients in South Africa
    Daftary, Amrita
    Padayatchi, Nesri
    O'Donnell, Max
    GLOBAL PUBLIC HEALTH, 2014, 9 (09) : 1107 - 1116
  • [8] Patients' priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia
    South, Annabelle
    Dhesi, Parveen
    Tweed, Conor D. D.
    Tsogt, Bazarragchaa
    Staples, Suzanne
    Tukvadze, Nestani
    Dorj, Gantsetseg
    Zaca, Sindisiwe
    Sanikidze, Ekaterine
    Purev, Nasanjargal
    Esmail, Hanif
    Burgess, Rochelle
    GLOBAL PUBLIC HEALTH, 2023, 18 (01)
  • [9] Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
    Pietersen, Elize
    Ignatius, Elisa
    Streicher, Elizabeth M.
    Mastrapa, Barbara
    Padanilam, Xavier
    Pooran, Anil
    Badri, Motasim
    Lesosky, Maia
    van Helden, Paul
    Sirgel, Frederick A.
    Warren, Robin
    Dheda, Keertan
    LANCET, 2014, 383 (9924) : 1230 - 1239
  • [10] Adherence in the Treatment of Patients With Extensively Drug-Resistant Tuberculosis and HIV in South Africa: A Prospective Cohort Study
    O'Donnell, Max R.
    Wolf, Allison
    Werner, Lise
    Horsburgh, C. Robert
    Padayatchi, Nesri
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (01) : 22 - 29